Table 4.
Group | 6 h | 24 h | 48 h | |||
---|---|---|---|---|---|---|
Serum triglyceride(mg/dl) | Serum VLDL(mg/dl) | Serum Triglyceride(mg/dl) | Serum VLDL(mg/dl) | Serum Triglyceride(mg/dl) | Serum VLDL(mg/dl) | |
Control | 69.4 ± 0.71 | 13.72 ± 0.96 | 61.17 ± 0.84 | 12.10 ± 0.89 | 79.40 ± 1.34 | 15.81 ± 1.01 |
BVSW200 | 63.72 ± 1.362c | 12.66 ± 0.881a | 60.22 ± 0.821a | 20.17 ± 1.01 | 54.47 ± 0.662a,2b,2c | 10.84 ± 0.802a,2b,2c |
BVSW400 | 60.77 ± 1.392c | 12.10 ± 0.941a,1b,1c | 57.65 ± 0.702a,2c | 11.50 ± 0.881a,1b | 54.56 ± 0.742a,2b,2c | 10.89 ± 0.852a,2b,2c |
BVRW200 | 68.32 ± 0.52 | 13.66 ± 0.73 | 54.17 ± 0.662a,1b,2c | 10.71 ± 1.001a,1b | 59.68 ± 1.732a,1b,2c | 11.82 ± 0.862a,2b,2c |
BVRW400 | 63.43 ± 0.792c | 12.60 ± 0.87 | 54.55 ± 0.822a,1b,2c | 10.81 ± 0.821a,1b | 50.29 ± 0.692a,2b,2c | 10.18 ± 0.812a,2b,2c |
BVSA200 | 62.50 ± 0.872c | 12.46 ± 0.86 | 51.61 ± 0.62a,1b,2c | 10.43 ± 0.761a,1b,1c | 49.45 ± 0.662a,2b,2c | 09.75 ± 0.883a,3b,2c |
BVSA400 | 60.18 ± 1.012c | 11.90 ± 0.781c | 52.31 ± 0.672a,2c | 10.42 ± 0.711a,1b,1c | 43.67 ± 0.732a,3b,2c | 8.84 ± 0.833a,3b,2c |
BVRA200 | 67.48 ± 1.522c | 13.48 ± 0.85 | 58.46 ± 4.162a,1b,2c | 12.20 ± 0.891a,1b | 48.26 ± 0.713a,3b,2c | 12.13 ± 0.903a,3b,2c |
BVRA400 | 60.55 ± 0.702c | 12.23 ± 0.832c | 50.89 ± 1.062a,2b,2c | 10.56 ± 0.751a | 48.45 ± 0.683a,3b,2c | 09.60 ± 0.773a,3b,2c |
Simvastatin | 63.73 ± 1.712c | 12.66 ± 0.861b | 63.24 ± 0.91 | 12.50 ± 0.86 | 65.34 ± 0.752b,2c | 13.19 ± 0.951b,2c |
Fenofibrate | 55.20 ± 0.983a,2c | 11.34 ± 0.321a | 54.11 ± 0.713a,2c | 10.84 ± 0.641a | 58.58 ± 1.272a,2c | 11.91 ± 0.752a,2c |
Values are expressed as mean ± S.D. (n = 6). Triglyceride and VLDL concentrations are estimated by the standard method and the values are expressed as mg/dl serum; 1P < 0.05, 2P < 0.01, 3P < 0.001, when compared with the ccontrol group; aSimvastatin; bFenofibrate; BVRW, BVRA, BVSW, BVSA: Bauhinia variegata root water, ethanolic and Bauhinia variegata stem water and ethanolic extracts, respectively, at 200 and 400 mg/kg body weight